Page 84 - Pagetit

3. BIOBEHAVIOURAL PROCESSES UNDERLYING DEPENDENCE

Jaffe JH (1985) Drug addiction and drug abuse. In: Gilman AG, Goodman LS, Rall
TW, eds. Goodman and Gilman’s: The pharmacological basis of therapeutics,
7th ed. New York, NY, MacMillan:522–573.
Jaffe JH (1990) Drug addiction and drug use. In: Gilman AG et al., eds. Goodman
and Gilman’s: The pharmacological basis of therapeutics, 8th ed. New York, NY,
Pergamon Press: 522–573.
Johanson CE, Uhlenhuth EH (1978) Drug self-administration in humans. NIDA
Research Monograph, 20:68–85.
Johanson CE, Kilgore K, Uhlenhuth EH (1983) Assessment of dependence
potential of drugs in humans using multiple indices. Psychopharmacology,
81:144–149.
Koob GF et al. (1989) Opponent process theory of motivation: neurobiological
evidence from studies of opiate dependence. Neuroscience and Biobehavioral
Reviews, 13:135–140.
Koob GF et al. (1997) Opponent process model and psychostimulant addiction.
Pharmacology, Biochemistry and Behavior, 57:513–521.
Lewander T (1974) Effect of chronic treatment with central stimulants on brain
monoamines and some behavioral and physiological functions in rats, guinea
pigs, and rabbits. In: Usdin E, ed. Advances in biochemical psychopharmacology.
Vol. 12. Neuropsychopharmacology of monoamines and their regulatory enzymes.
New York, NY, Raven Press:221–239.
Marinelli M, Le Moal M, Piazza PV (1998) Sensitization to the motor effects of
contingent infusions of heroin but not of kappa agonist RU 51599. Psychopharma-
cology (Berlin), 139:281–285.
Montague PR, Dayan P, Sejnowski TJ (1996) A framework for mesencephalic
dopamine systems based on predictive Hebbian learning. Journal of Neuroscience,
16:1936–1947.
O’Brien CP et al. (1992) Classical conditioning in drug-dependent humans. Annals
of the New York Academy of Sciences, 654:400–415.
Paulson PE, Camp DM, Robinson TE (1991) Time course of transient behavioral
depression and persistent behavioral sensitization in relation to regional brain
monoamine concentrations during amphetamine withdrawal in rats. Psycho-
pharmacology (Berlin), 103:480–492.
Perez-Reyes M et al. (1991) Clinical effects of daily methamphetamine
administration. Clinical Neuropharmacology, 14:352–358.
Phillips AG, Fibiger HC (1979) Decreased resistance to extinction after halope-
ridol: implications for the role of dopamine in reinforcement. Pharmacology,
Biochemistry and Behavior, 10:751–760.
Phillips AG, Di Ciano P (1996) Behavioral sensitization is induced by intravenous
self-administration of cocaine by rats. Psychopharmacology (Berlin), 124:279–
281.
Piazza PV et al. (1990) Individual reactivity to novelty predicts probability of
amphetamine self-administration. Behavioural Pharmacology, 1:339–345.
Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine and
amphetamine preferentially increase extracellular dopamine in the “shell” as

63

Chapter_3 63 19.1.2004, 11:38